Monosodium glutamate neonatal treatment induces cardiovascular autonomic function changes in rodents
AUTOR(ES)
Konrad, Signorá Peres, Farah, Vera, Rodrigues, Bruno, Wichi, Rogério Brandão, Machado, Ubiratan Fabres, Lopes, Heno Ferreira, Schaan, Beatriz D'Agord, Angelis, Kátia De, Irigoyen, Maria Cláudia
FONTE
Clinics
DATA DE PUBLICAÇÃO
2012-10
RESUMO
OBJECTIVES: The aim of this study was to evaluate cardiovascular autonomic function in a rodent obesity model induced by monosodium glutamate injections during the first seven days of life. METHOD: The animals were assigned to control (control, n = 10) and monosodium glutamate (monosodium glutamate, n = 13) groups. Thirty-three weeks after birth, arterial and venous catheters were implanted for arterial pressure measurements, drug administration, and blood sampling. Baroreflex sensitivity was evaluated according to the tachycardic and bradycardic responses induced by sodium nitroprusside and phenylephrine infusion, respectively. Sympathetic and vagal effects were determined by administering methylatropine and propranolol. RESULTS: Body weight, Lee index, and epididymal white adipose tissue values were higher in the monosodium glutamate group in comparison to the control group. The monosodium glutamate-treated rats displayed insulin resistance, as shown by a reduced glucose/insulin index (-62.5%), an increased area under the curve of total insulin secretion during glucose overload (39.3%), and basal hyperinsulinemia. The mean arterial pressure values were higher in the monosodium glutamate rats, whereas heart rate variability (>7 times), bradycardic responses (>4 times), and vagal (~38%) and sympathetic effects (~36%) were reduced as compared to the control group. CONCLUSION: Our results suggest that obesity induced by neonatal monosodium glutamate treatment impairs cardiac autonomic function and most likely contributes to increased arterial pressure and insulin resistance.
Documentos Relacionados
- Autonomic neuropathy in systemic lupus erythematosus: cardiovascular autonomic function assessment.
- Effects of Seizures on Autonomic and Cardiovascular Function
- Normal cardiovascular autonomic function in patients with systemic sclerosis (CREST variant).
- Repeatability of measurements and sources of variability in tests of cardiovascular autonomic function
- Cardiovascular tests of autonomic function and sympathetic skin responses in patients with major depression.